share_log

Chemed Corporation's (NYSE:CHE) CEO Compensation Looks Acceptable To Us And Here's Why

Chemed Corporation's (NYSE:CHE) CEO Compensation Looks Acceptable To Us And Here's Why

Chemed Corporation(纽约证券交易所代码:CHE)首席执行官的薪酬对我们来说似乎是可以接受的,原因如下
Simply Wall St ·  05/14 18:11

Key Insights

关键见解

  • Chemed will host its Annual General Meeting on 20th of May
  • Total pay for CEO Kevin McNamara includes US$1.60m salary
  • The total compensation is similar to the average for the industry
  • Over the past three years, Chemed's EPS fell by 3.0% and over the past three years, the total shareholder return was 20%
  • Chemed 将于 5 月 20 日举办年度股东大会
  • 首席执行官凯文·麦克纳马拉的总薪水包括160万美元的工资
  • 总薪酬与该行业的平均水平相似
  • 在过去三年中,Chemed的每股收益下降了3.0%,在过去三年中,股东总回报率为20%

Despite positive share price growth of 20% for Chemed Corporation (NYSE:CHE) over the last few years, earnings growth has been disappointing, which suggests something is amiss. These concerns will be at the front of shareholders' minds as they go into the AGM coming up on 20th of May. They will be able to influence managerial decisions through the exercise of their voting power on resolutions, such as CEO remuneration and other matters, which may influence future company prospects. In our analysis below, we show why shareholders may consider holding off a raise for the CEO's compensation until company performance improves.

尽管在过去几年中,Chemed Corporation(纽约证券交易所代码:CHE)的股价增长了20%,但收益增长令人失望,这表明有些不对劲。在即将于5月20日举行的股东周年大会之际,这些担忧将成为股东的头等大事。他们将能够通过对诸如首席执行官薪酬和其他可能影响公司未来前景的决议行使投票权来影响管理层的决策。在下面的分析中,我们将说明为什么股东可能会考虑在公司业绩改善之前推迟提高首席执行官的薪酬。

How Does Total Compensation For Kevin McNamara Compare With Other Companies In The Industry?

与业内其他公司相比,凯文·麦克纳马拉的总薪酬如何?

At the time of writing, our data shows that Chemed Corporation has a market capitalization of US$8.6b, and reported total annual CEO compensation of US$13m for the year to December 2023. We note that's an increase of 8.8% above last year. While we always look at total compensation first, our analysis shows that the salary component is less, at US$1.6m.

在撰写本文时,我们的数据显示,Chemed Corporation的市值为86亿美元,并报告称,截至2023年12月的一年中,首席执行官的年薪总额为1300万美元。我们注意到这比去年增长了8.8%。虽然我们总是首先考虑总薪酬,但我们的分析表明,薪资部分较低,为160万美元。

In comparison with other companies in the American Healthcare industry with market capitalizations ranging from US$4.0b to US$12b, the reported median CEO total compensation was US$11m. So it looks like Chemed compensates Kevin McNamara in line with the median for the industry. What's more, Kevin McNamara holds US$64m worth of shares in the company in their own name, indicating that they have a lot of skin in the game.

与美国医疗保健行业其他市值从40亿美元到120亿美元不等的公司相比,报告的首席执行官总薪酬中位数为1100万美元。因此,看来Chemed对凯文·麦克纳马拉的补偿与该行业的中位数一致。更重要的是,凯文·麦克纳马拉以自己的名义持有该公司价值6400万美元的股份,这表明他们在游戏中拥有大量股份。

Component 2023 2022 Proportion (2023)
Salary US$1.6m US$1.5m 13%
Other US$11m US$10m 87%
Total Compensation US$13m US$12m 100%
组件 2023 2022 比例 (2023)
工资 160 万美元 150 万美元 13%
其他 1100 万美元 一千万美元 87%
总薪酬 1300 万美元 1200 万美元 100%

On an industry level, roughly 22% of total compensation represents salary and 78% is other remuneration. Chemed pays a modest slice of remuneration through salary, as compared to the broader industry. It's important to note that a slant towards non-salary compensation suggests that total pay is tied to the company's performance.

在行业层面上,总薪酬中约有22%代表工资,78%是其他薪酬。与整个行业相比,Chemed通过工资支付的薪酬微不足道。值得注意的是,对非工资薪酬的倾向表明,总薪酬与公司的业绩挂钩。

ceo-compensation
NYSE:CHE CEO Compensation May 14th 2024
纽约证券交易所:CHE 首席执行官薪酬 2024 年 5 月 14 日

A Look at Chemed Corporation's Growth Numbers

看看Chemed Corporation的增长数字

Over the last three years, Chemed Corporation has shrunk its earnings per share by 3.0% per year. It achieved revenue growth of 6.0% over the last year.

在过去的三年中,Chemed Corporation的每股收益每年缩水3.0%。去年,它实现了6.0%的收入增长。

Overall this is not a very positive result for shareholders. The modest increase in revenue in the last year isn't enough to make us overlook the disappointing change in EPS. These factors suggest that the business performance wouldn't really justify a high pay packet for the CEO. Moving away from current form for a second, it could be important to check this free visual depiction of what analysts expect for the future.

总体而言,这对股东来说并不是一个非常积极的结果。去年收入的温和增长不足以让我们忽视每股收益令人失望的变化。这些因素表明,业务表现并不能真正证明首席执行官的高薪是合理的。暂时偏离目前的形式,查看这份对分析师未来预期的免费可视化描述可能很重要。

Has Chemed Corporation Been A Good Investment?

Chemed Corporation 是一项不错的投资吗?

Chemed Corporation has generated a total shareholder return of 20% over three years, so most shareholders would be reasonably content. But they probably don't want to see the CEO paid more than is normal for companies around the same size.

Chemed Corporation在三年内创造了20%的股东总回报率,因此大多数股东会感到满意。但是他们可能不希望看到首席执行官为相同规模的公司支付的薪水超过正常水平。

In Summary...

总而言之...

Shareholder returns, while positive, should be looked at along with earnings, which have not grown at all recently. This makes us think the share price momentum may slow in the future. The upcoming AGM will provide shareholders the opportunity to revisit the company's remuneration policies and evaluate if the board's judgement and decision-making is aligned with that of the company's shareholders.

股东回报虽然是积极的,但应与收益一起考虑,因为收益最近根本没有增长。这使我们认为未来股价势头可能会放缓。即将举行的股东周年大会将使股东有机会重新审视公司的薪酬政策,并评估董事会的判断和决策是否与公司股东的判断和决策一致。

While it is important to pay attention to CEO remuneration, investors should also consider other elements of the business. That's why we did some digging and identified 1 warning sign for Chemed that investors should think about before committing capital to this stock.

尽管关注首席执行官的薪酬很重要,但投资者还应考虑业务的其他要素。这就是为什么我们进行了一些挖掘并确定了Chemed的一个警告信号,投资者在向该股票投入资金之前应该考虑这个信号。

Switching gears from Chemed, if you're hunting for a pristine balance sheet and premium returns, this free list of high return, low debt companies is a great place to look.

如果你正在寻找原始的资产负债表和保费回报,那么这份免费的高回报、低负债公司的清单是一个不错的选择。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发